O'Shaughnessy Asset Management, LLC Grifols Sa Transaction History

O'Shaughnessy Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$16.62 - $18.94 $1,346 - $1,534	-81 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$18.24 - $21.45 $1,477 - $1,737	81 New	81 $1,000
Q1 2020 May 13, 2020	SELL	$16.28 - $25.63 $5,779 - $9,098	-355 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$19.57 - $23.52 $6,947 - $8,349	355 New	355 $8,000
Q2 2018 Aug 10, 2018	SELL	$20.16 - $24.68 $14,535 - $17,794	-721 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$20.31 - $24.95 $28,779 - $35,354	-1,417 Reduced 66.28%	721 $15,000
Q4 2017 Feb 13, 2018	SELL	$20.99 - $23.89 $54,217 - $61,707	-2,583 Reduced 54.71%	2,138 $49,000
Q3 2017 Nov 13, 2017	BUY	$20.07 - $21.89 $2,287 - $2,495	114 Added 2.47%	4,721 $103,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,607	4,607 $97,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.48B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.